Markus Wartmann

5PUBLICATIONS
31CO-AUTHORS
Molecular targetsPowder and particle technologyMedical molecular engineering of nucleic acids and proteinsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 09, 2025
Fragment-based discovery enables direct targeting of the melanoma oncogene MITF.

Deborah Castelletti, Jürgen Hinrichs, Goran Malojčić

|Jun 17, 2024
Author Correction: Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Emilie A Chapeau, Laurent Sansregret, Giorgio G Galli

|Apr 24, 2024
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.

Stephane Ferretti, Jacques Hamon, Ruben de Kanter

|Apr 02, 2024
Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Emilie A Chapeau, Laurent Sansregret, Giorgio G Galli

|Jan 17, 2024
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas.

Ahmed M O Elbatsh, Ali Amin-Mansour, Anne Haberkorn

Pageof 1

Frequent Collaborators

3 joint publications

Clemens Scheufler

2 joint publications

Nicolas Soldermann

2 joint publications

Luca Tordella

2 joint publications

Emilie A Chapeau